Fast Money 11/26/25
CNBC's "Fast Money"
00:00
Obesity Drug Category's Systemic Impact
Len argues incretin/amylin drugs reduce morbidity, save costs, and drive long-term market growth for drugmakers.
Play episode from 42:08
Transcript
Len argues incretin/amylin drugs reduce morbidity, save costs, and drive long-term market growth for drugmakers.
